Trident Lifeline, a company in the Pharmaceuticals industry, reported revenue of ₹47 crore and net profit of ₹6.60 crore for the September 2026 quarter.
Trident Lifeline (BSE: TLL) closed at ₹406.05 on 20 Nov 2026, up 30.2% over the past year. Its market capitalisation is ₹486 crore and it trades at 21.5 times earnings.
Incorporated in 2014, Trident Lifeline Ltd manufactures and sells pharmaceuticals products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.